Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Mar 15;18(5):2046960. doi: 10.1080/21645515.2022.2046960

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2022 Merck & Co., Inc. Published with license by Taylor & Francis Group, LLC.

This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.

PMC Copyright notice

Figure 3. — Vaccine viremia after each vaccination, stratified by baseline flavivirus serostatus.

Bars (and numbers above each bar) show the percent of participants with demonstrated vaccine viremia in at least one time point (Day 7, 12, or 28) after vaccination. Viremia was measured for each dengue serotype, and any dengue viremia (Any DENV) is defined as demonstrated viremia to at least one serotype at least one time point tested. Error bars represent the 95% confidence intervals. Full Analysis Set Population is shown. TV003=V181 TV003 formulation, TV005=V181 TV005 formulation, BFE=baseline flavivirus experienced, BFN=baseline flavivirus naïve.